OKYO Pharma (OKYO) announces the filing of its application for Fast Track designation, FTD, with the U.S. Food and Drug Administration, FDA, for urcosimod for the treatment of neuropathic corneal ...

HERZLIYA, Israel and CALGARY, AB, March 7, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it has ...

SAN DIEGO (FOX 5/KUSI) — The former vice president of Acadia Pharmaceuticals Inc., headquartered in Sorrento Valley, pleaded guilty Friday to insider trading. George Demos, 64, of San Diego ...

HERZLIYA, Israel and CALGARY, AB, March 7, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it has closed its ...

An icon of 3 horizontal dots. An icon of a paper envelope. An icon of a facebook f logo. An icon of a digital camera. An icon of a house. An icon of the Instagram logo. An icon of the LinkedIn logo.

RANCHO CUCAMONGA, CA / ACCESS Newswire / March 5, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical ...

DUBLIN and DURHAM, N.C., March 5, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz" or the "Company") and Chimerix (Nasdaq: CMRX) ("Chimerix ...

The Company provided the above adjusted supplemental financial performance measures, which are considered "non-GAAP" financial measures under applicable SEC rules and regulations. These financial ...

Good day, and thank you for standing by. Welcome to Madrigal Pharmaceuticals' Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in listen-only mode.

However, I think aggressive growth investors might want to consider buying Madrigal Pharmaceuticals' shares. Some analysts project that Rezdiffra could generate peak annual sales of close to $3.5 ...

Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Alnylam Pharma (ALNY – Research Report) today and set a price target of $300.00. The company’s shares closed yesterday at $245.20.

Pakistan Single Window (PSW) CEO Syed Aftab Haider has said that digitalisation of regulatory processes will simplify compliance requirement and help pharmaceutical firms to reduce the time and ...